Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-22-Speech-1-160"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101122.17.1-160"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Madam President, just like Mr Ouzký, I, too, have devoted my professional career as a doctor to the question of how better to inform my patients. However, it is customary to begin by applauding the good work of the rapporteur, and I would like to do this, although with a minor criticism which I will return to later.
When we began negotiating this proposal, we faced two problems following the election of the new Commission. First, the issue had transferred to a new Commissioner, and second, we faced a problem over whether to continue the work started, or to throw away the existing document and start afresh.
Just like most of you and Commissioner Dalli, I agreed that the original Commission proposal was not a good one, as it did not address the needs of patients and consumers. We therefore did not want to lose time working together on the old document. We agreed to reject the commercial campaign mounted by the pharmaceutical companies. We ruled out print media as a communications channel, and we agreed that patients had a right to know who was providing information, and that companies were responsible for all the information they disseminated.
I am rather surprised that Mr Fjellner is again submitting to the plenary an amendment proposal which we rejected in the committee and which would be a retrograde step, contrary to the amended wording of the proposal. If such a proposal were to be adopted, I would find it difficult to vote for what is generally a decent document."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples